Dr. Jon Arnason, MD
Claim this profileBeth Israel Deaconess Medical Center
Expert in Lymphoma
Studies Chronic B-Cell Leukemia
15 reported clinical trials
24 drugs studied
Area of expertise
1Lymphoma
Global LeaderBCL6 positive
BCL2 positive
MYC positive
2Chronic B-Cell Leukemia
TP53 positive
Del(17p) positive
CD5 positive
Affiliated Hospitals
Clinical Trials Jon Arnason, MD is currently running
CTO1681
for Preventing Side Effects in Cancer Therapy
This is an interventional study to evaluate the use of CTO1681 in preventing or reducing CAR T-cell-induced toxicities like cytokine release syndrome (CRS). This study will enroll adult patients with DLBCL who are scheduled to receive CD19-directed CAR T-cell therapy. The first phase of the study will be open label with dose escalation. Participants will start taking CTO1681 just prior to receiving their CAR T-cell therapy and continue to take the study drug three times daily for a total of 15 days.
Recruiting1 award Phase 1 & 2
JCAR017
for Chronic Leukemia or Lymphoma
This trial tests JCAR017, a therapy using modified immune cells, in adults with hard-to-treat CLL or SLL. It aims to see if these enhanced immune cells can better fight the cancer.
Recruiting1 award Phase 1 & 2
More about Jon Arnason, MD
Clinical Trial Related1 year of experience running clinical trials · Led 15 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Jon Arnason, MD has experience with
- Venetoclax
- Acalabrutinib
- Obinutuzumab
- Umbralisib
- Rituximab
- Zanubrutinib
Breakdown of trials Jon Arnason, MD has run
Lymphoma
Chronic B-Cell Leukemia
Chronic Lymphocytic Leukemia
Lymphoid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jon Arnason, MD specialize in?
Jon Arnason, MD focuses on Lymphoma and Chronic B-Cell Leukemia. In particular, much of their work with Lymphoma has involved BCL6 positive patients, or patients who are BCL2 positive.
Is Jon Arnason, MD currently recruiting for clinical trials?
Yes, Jon Arnason, MD is currently recruiting for 7 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Jon Arnason, MD has studied deeply?
Yes, Jon Arnason, MD has studied treatments such as Venetoclax, Acalabrutinib, Obinutuzumab.
What is the best way to schedule an appointment with Jon Arnason, MD?
Apply for one of the trials that Jon Arnason, MD is conducting.
What is the office address of Jon Arnason, MD?
The office of Jon Arnason, MD is located at: Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215 United States. This is the address for their practice at the Beth Israel Deaconess Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.